Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?

Background: Vedolizumab trough serum levels have been associated with clinical and endoscopic response in patients with inflammatory bowel disease (IBD). A recent study demonstrated that higher trough levels before dose escalation are associated with favorable outcomes. Objectives: We aimed to ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Levartovsky, Asaf, Cohen, Ido, Abitbol, Chaya Mushka, Yavzori, Miri, Fudim, Ella, Picard, Orit, Kopylov, Uri, Ben-Horin, Shomron, Ungar, Bella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295644/
https://www.ncbi.nlm.nih.gov/pubmed/37371648
http://dx.doi.org/10.3390/biomedicines11061553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295644/
https://www.ncbi.nlm.nih.gov/pubmed/37371648
http://dx.doi.org/10.3390/biomedicines11061553

Ejemplares similares